Similar Search Results

Narrow search

Realoptionen als Controlling-Instrument : das Beispiel pharmazeutische Forschung und Entwicklung

Pritsch, Gunnar - 2000 - 1. Aufl.

Persistent link: https://www.econbiz.de/10001506460

The dynamics of pharmaceutical regulation and R&D investments

Levaggi, Rosella; Moretto, Michele; Pertile, Paolo - In: Journal of public economic theory 19 (2017) 1, pp. 121-141

Persistent link: https://www.econbiz.de/10011721676

Hazardous to our health? : FDA regulation of health care products

Higgs, Robert (contributor) - 1995

Persistent link: https://www.econbiz.de/10000549765

Regulation and drug development

Wardell, William M.; Lasagna, Louis - 1975

Persistent link: https://www.econbiz.de/10000584247

How health care reform affects pharmaceutical research and development

Cook, Anna (contributor); Webre, Philip C. (contributor) - 1994

Persistent link: https://www.econbiz.de/10000426441

Regulatory policy, value of knowledge assets and innovation strategy : the case of the Orphan Drug Act

Rzakhanov, Zaur - In: Research policy : policy, management and economic … 37 (2008) 4, pp. 673-689

Persistent link: https://www.econbiz.de/10003715781

The effect of advertising on pharmaceutical innovation

Kwong, Winghan Jacqueline; Norton, Edward C. - In: Review of industrial organization : RIO 31 (2007) 3, pp. 221-236

Persistent link: https://www.econbiz.de/10003718431

Outsourcing drug investigations to India : a comment on U.S., Indian, and international regulation of clinical trials in cross-border pharmaceutical research

Cekola, James - In: Northwestern journal of international law & business 28 (2007) 1, pp. 125-145

Persistent link: https://www.econbiz.de/10003728110

Influence, information overload, and information technology in health care

Rebitzer, James B.; Rege, Mari; Shepard, Christopher - 2008

"We investigate whether information technology can help physicians more efficiently acquire new knowledge in a clinical environment characterized by information overload. Our analysis makes use of data from a randomized trial as well as a theoretical model of the influence that information...

Persistent link: https://www.econbiz.de/10003739202

Market incentives and pharmaceutical innovation

Yin, Wesley - In: Journal of health economics 27 (2008) 4, pp. 1060-1077

Persistent link: https://www.econbiz.de/10003743203

A service of the

zbw